You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Angiotensin II receptor blocker

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coarctation of Aorta, High Blood Pressure Trial in Rochester (Losartan, Amlodipine, Placebo)

Not yet recruiting
  • Coarctation of Aorta
  • High Blood Pressure
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 21, 2023

Cardiovascular Diseases, Hypertension Trial in San Francisco (Losartan, Placebo)

Recruiting
  • Cardiovascular Diseases
  • Hypertension
  • San Francisco, California
    San Francisco Veterans' Affairs Medical Center
Apr 29, 2022

Pulmonary Hypertension Trial in Badalona (Sacubitril / Valsartan Oral Tablet [Entresto])

Completed
  • Pulmonary Hypertension
  • Sacubitril / Valsartan Oral Tablet [Entresto]
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol University Hospital
Sep 23, 2021

Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)

Not yet recruiting
  • Aortic Valve Stenosis
  • +5 more
  • Limoges, France
    Limoges university hospital
Dec 23, 2022

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li，MD
Apr 18, 2023

Heart Failure Trial in Saga (Sacubitril Valsartan Sodium Hydrate, Standard treatment)

Recruiting
  • Heart Failure
  • Sacubitril Valsartan Sodium Hydrate
  • Standard treatment
  • Saga, Japan
    Saga University Hospital
Dec 27, 2021

Idiopathic Membranous Nephropathy Trial in Aarhus (100 mg AP1189, Placebo)

Recruiting
  • Idiopathic Membranous Nephropathy
  • 100 mg AP1189
  • Placebo
  • Aarhus, Denmark
    Aarhus Universitetshospital
Sep 21, 2021

Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in United States (drug, behavioral, other)

Completed
  • Cognitively Normal Older Adults
  • +3 more
  • Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)
  • +3 more
  • Kansas City, Kansas
  • +3 more
Feb 12, 2022

SARS-CoV Infection Trial in La Mesa, San Diego (Losartan)

Completed
Has Results
  • SARS-CoV Infection
  • La Mesa, California
  • +2 more
May 24, 2021

SARS-CoV-2, COVID-19 Trial in Austria, Germany (ACE inhibitor, angiotensin receptor blocker)

Completed
Has Results
  • SARS-CoV-2
  • COVID-19
  • ACE inhibitor, angiotensin receptor blocker
  • Innsbruck, Tyrol, Austria
  • +30 more
Aug 18, 2022

Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2

Recruiting
  • Diabetes Mellitus
  • Cardiovascular Diseases
  • Renin-angiotensin-aldosterone system inhibitors
  • +2 more
  • Singapore, Singapore
    Singapore General Hospital (SGH)
Apr 28, 2021

Acute Kidney Injury Trial (IRBESARTAN, tablet, 150 mg, Placebo, tablet, 150 mg)

Not yet recruiting
  • Acute Kidney Injury
  • IRBESARTAN, tablet, 150 mg
  • Placebo, tablet, 150 mg
  • (no location specified)
Aug 8, 2022

Myocardial Infarction With Non-obstructive Coronary Arteries Trial in Worldwide (Beta blocker, ACEI, ARB)

Recruiting
  • Myocardial Infarction With Non-obstructive Coronary Arteries
  • Beta blocker
  • +2 more
  • Adelaide, Sout Australi, Australia
  • +19 more
Sep 6, 2021

Hypertension Trial in London (Preoperative ACEi/ARB management)

Completed
  • Hypertension
  • Preoperative ACEi/ARB management
  • London, Ontario, Canada
    London Health Sciences Centre
Oct 21, 2021

COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

Recruiting
  • COVID-19
  • SARS-CoV2 Infection
  • Candesartan Cilexetil
  • +3 more
  • Guntur, India
  • +4 more
Mar 13, 2022

Heart Failure, Systolic Trial in Karachi (Sacubitril/valsartan)

Completed
  • Heart Failure, Systolic
  • Karachi, Sindh, Pakistan
    National Institute of Cardiovascular Diseases
May 20, 2022

Preeclampsia Postpartum Trial in Iowa City (Losartan Potassium, Placebo)

Recruiting
  • Preeclampsia Postpartum
  • Losartan Potassium
  • Placebo
  • Iowa City, Iowa
    University of Iowa
May 16, 2022

AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)

Recruiting
  • AML
  • Acute Myeloid Leukemia
  • Charlottesville, Virginia
    University of Virginia
Jul 2, 2022

Chronic Kidney Disease, Hypertension, Hyperkalemia Trial in Worldwide (patiromer, losartan, spironolactone)

Completed
Has Results
  • Chronic Kidney Disease
  • +2 more
  • Karlovac, Croatia
  • +42 more
May 10, 2021

Covid-19 Trial in Hellerup, Herlev (Discontinuation of ACEi/ARB, Continuation of ACEi/ARB)

Completed
  • Covid-19
  • Discontinuation of ACEi/ARB
  • Continuation of ACEi/ARB
  • Hellerup, Capital Region Of Denmark, Denmark
  • +1 more
Jan 17, 2023

Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

Recruiting
  • Kidney Disease
  • Chula Vista, California
  • +5 more
Jan 23, 2023

Coronavirus Disease(COVID)-19 Acute Respiratory Distress

Recruiting
  • COVID
  • Acute Respiratory Distress Syndrome
  • Angiotensin II
  • Interleukin-1 receptor antagonist
  • London, United Kingdom
    Guy's & St Thomas' Hospital
Aug 3, 2021

Heart Failure With Reduced Ejection Fraction Trial in Los Angeles (Email Nudge)

Not yet recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Email Nudge
  • Los Angeles, California
    University of California, Los Angeles
Apr 7, 2023

COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II

Recruiting
  • COVID-19
  • Cardiovascular Diseases
  • Angiotensin converting enzyme inhibitor
  • Angiotensin II Receptor Blockers
  • Maceio, Alagoas, Brazil
  • +30 more
Jan 13, 2023

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Completed
  • Hypertension
  • COVID
  • Salt Lake City, Utah
    University of Utah
Apr 26, 2021